Plaque Psoriasis Clinical Trials 2024

Plaque Psoriasis Clinical Trials 2024

Plaque Psoriasis research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in plaque psoriasis clinical trials today.

Plaque Psoriasis Clinical Trials

Here are the 6 most popular medical studies for plaque psoriasis

Popular filter options for plaque psoriasis trials

Psoriasis Clinical Trials

View 45 Psoriasis medical studies.

Phase 3 Plaque Psoriasis Clinical Trials

View 73 phase 3 plaque psoriasis medical studies.

Plaque Psoriasis Clinical Trials With No Placebo

View 73 plaque psoriasis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to plaque psoriasis

What are the top hospitals conducting plaque psoriasis research?

When it comes to pioneering clinical trials in the treatment of plaque psoriasis, several hospitals are making notable strides. In Houston, the Center for Clinical Studies is leading the way with three ongoing trials focused on this dermatological condition. With a total of 32 conducted studies dedicated to plaque psoriasis since their first recorded trial in 2004, this center has solidified its position as a prominent player in the field. Meanwhile, Brigham and Women's Hospital in Boston is also actively involved in advancing treatments for plaque psoriasis through their three currently active trials and their early involvement starting from 2003 with five completed studies.

On the East Coast, The Psoriasis Treatment Center of Central New jersey located at East Windsor offers hope to patients living with plaque psoriasis through its dedication to research. This institution has initiated three active clinical trials focused on finding effective therapies for this condition since recording its inaugural trial in 2015. Alongside these determined efforts lies Wake Forest University Health Sciences based in Winston-Salem where they too have enkindled required enthusiasm by conducting eighteen experiments until now from commencing investigation about such cases back during year- 2006.

Although Skin Sciences, PLLC may seem relatively new compared to other institutions listed here, located in Louisville they contribute significantly towards medical advancements by actively participating via two ongoing clinical tests while already having four previously held investigations under their belt; all being related exclusively towards understanding Plaque Psoriasis beginning only after recording particular type of experiment attached back during uncertain times i.e.,2017

These esteemed hospitals signify not only remarkable progress but also unwavering commitment when it comes to improving outcomes for those grappling with plaque psoriasis—a chronic skin condition that affects millions worldwide. Through rigorous research and innovative clinical trials conducted across these diverse locations over several years or even recently emerged expertise every small achievement brings us closer towards discovering breakthroughs that could ultimately transform lives affected by this complex disease

Which are the best cities for plaque psoriasis clinical trials?

When it comes to plaque psoriasis clinical trials, several cities have emerged as leading hubs for research. Miami, Florida takes the lead with 21 active trials investigating treatments like BMS-986165, Tildrakizumab, and Brodalumab. Following closely behind is New york City with 16 ongoing studies exploring options such as Nivolumab, risankizumab, and Rimegepant. Houston, Texas also shows promise in this field with 15 active trials focusing on risankizumab and other treatments like Guselkumab and Deucravacitinib. These three cities offer individuals suffering from plaque psoriasis an array of cutting-edge clinical trials that may pave the way for improved management of this chronic skin condition.

Which are the top treatments for plaque psoriasis being explored in clinical trials?

Plaque psoriasis research is rapidly advancing, with several promising treatments being explored in clinical trials. At the forefront is deucravacitinib, currently involved in three active trials and a total of six all-time plaque psoriasis trials since its introduction in 2021. Close behind is risankizumab, making strides with two ongoing trials and eleven all-time plaque psoriasis studies since 2016. Another noteworthy contender is ustekinumab, showing potential through two active trials and an impressive history of twenty-nine all-time plaque psoriasis clinical trials dating back to 2003. Lastly, guselkumab also joins the race with two current investigations and twenty-two previous plaque psoriasis studies since its first listing in 2013. These innovative therapies bring renewed hope for those living with plaque psoriasis as researchers continue their efforts towards finding effective solutions.

What are the most recent clinical trials for plaque psoriasis?

Exciting progress is being made in the field of plaque psoriasis treatment, with recent clinical trials offering promising insights. One such trial focuses on guselkumab, a potential therapy for plaque psoriasis that has shown positive results in Phase 3 studies. Additionally, DC-806 Dose A and BMS-986322 Dose 1 have demonstrated potential as effective treatments based on their respective Phase 2 trials. Another study examined the use of VTAMA cream (tapinarof) at a concentration of 1% to treat plaque psoriasis in a real-world setting. These ongoing trials provide hope for individuals living with this challenging skin condition by identifying new options and refining existing therapies.

What plaque psoriasis clinical trials were recently completed?

Several recent clinical trials have made significant progress in the field of plaque psoriasis research, paving the way for improved treatments. In June 2022, Janssen Research & Development completed a trial investigating the potential of JNJ-77242113 therapy. Similarly, AnaptysBio successfully wrapped up their trial on Imsidolimab low dose in April 2022. Meiji Pharma USA Inc.'s study on ME3183 concluded in March 2022, while UNION therapeutics' investigation into Orismilast modified release tablets reached completion in December 2021. These advancements exemplify the commitment and dedication researchers have towards finding more effective solutions for patients struggling with plaque psoriasis.